Clinical trials
Phase 2 Carcinoma, Squamous Cell trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Daiichi Sankyo | 1 |
| Merck Sharp & Dohme LLC | 1 |
| PCI Biotech AS | 1 |
| QBiotics Group Limited | 1 |
| The Clatterbridge Cancer Centre NHS Foundation Trust | 1 |
| University College, London | 1 |
| University Hospital Southampton NHS Foundation Trust | 1 |
| University of Birmingham | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Squamous Cell | 8 |
| Head and Neck Neoplasms | 5 |
| Squamous Cell Carcinoma of Head and Neck | 2 |
| Adenocarcinoma | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Lung Neoplasms | 1 |
| Neoplasms | 1 |
| Neoplasms by Site | 1 |
| Recurrence | 1 |
| Salivary Gland Neoplasms | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.